JANSSEN-CILAG
Janssen is a pharmaceutical company that creates a future where disease is a thing of the past.
JANSSEN-CILAG
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2003-12-01
Address:
Budapest, Budapest, Hungary
Country:
Hungary
Website Url:
http://www.actelion.hu
Total Employee:
101+
Status:
Active
Contact:
36-1-4133270
Technology used in webpage:
IPv6 Google Apps For Business Microsoft Azure DNS Cloudflare Hosting Reddit Stumbleupon Digg Del.icio.us Mister Wong Add Url
Similar Organizations
Biropharma
Biropharma is a pharmaceutical company that produces herbal active ingredients, medicinal products, and food supplements.
Egis Gyógyszergyár
Egis operates as a generic pharmaceutical company that focuses on treating diseases of the cardiovascular and central nervous systems.
JRS Pharma
JRS Pharma is a pharmaceuticals company that provides excipients and coatings.
VitaLeech Bioscience
VitaLeech Bioscience develops a recombinant enzyme for the treatÂment of periodontitis, a form of inflammation of the gum.
Official Site Inspections
http://www.actelion.hu
- Host name: a6033b2998aeb1ff7.awsglobalaccelerator.com
- IP address: 99.83.186.106
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Janssen-Cilag"
Actelion Pharmaceuticals Hungaria Kft. - Céginformáció
Actelion Pharmaceuticals Hungaria Korlátolt FelelÅ‘sségű Társaság ... Ha adathiányt vagy téves adatot észlel, kérjük jelezze számunkra az [email protected] email címen. Amennyiben a jóhiszemű eljárás során a jelzést megalapozottnak a találjuk, a kifogásolt információt haladéktalanul töröljük, módosítjuk, vagy a ...See details»
Actelion - Wikipedia
Actelion was founded in 1997 by husband and wife team Jean-Paul and Martine Clozel together with three colleagues after F. Hoffmann-La Roche cut their funding for Martine's cardiovascular program. They founded Actelion to work on a drugs for rare diseases and retained the rights to the intellectual property from Roche, including the molecule leading to the development of Tracleer, a drug for treating pulmonary arterial hypertension (PAH) which became a billion dollar seller. See details»
Actelion Pharmaceuticals - Crunchbase Company …
Actelion Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of low molecular weight drugs for various …See details»
Actelion Pharmaceuticals - Contacts, Employees, Board Members, …
Actelion Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of low molecular weight drugs for ... Experience the new Crunchbase, powered by AI . Experience the new Crunchbase, powered by AI . Organization. Actelion Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology ...See details»
Team Actelion. In the 1980s, hundreds of …
May 26, 2015 By the end of 2003, Actelion had made an initial public offering of stock, introduced a first-in-class blockbuster …See details»
ACTELION’S COMPANY PROFILE - GlobeNewswire
ACTELION’S COMPANY PROFILE Actelion Ltd. is a leading biopharmaceutical company focused on the discovery, development and commercialization of innovative drugs for diseases with significant unmet medical needs. The company has its corporate headquarters in Allschwil/ Basel, Switzerland where it was founded in 1997. Its shares have been listed ...See details»
:: Actelion Global Laboratory::
Actelion Global Laboratory is a group of companies with a long history of experience in providing best technological process solutions to the pharmaceutical, Biotechnology and Cosmetic industries. The plant has an annual capacity of more than 3 billion oral solid dosage formulations. With an enviable location on the easily accessible San ...See details»
Actelion Pharmaceuticals Company Profile - Office Locations ...
Actelion Pharmaceuticals is a biopharmaceutical company focusing on the discovery, development, and commercialization of innovative treatments to serve high unmet medical needs. It is engaged in the development of tailored medicines to address pulmonary arterial hypertension (PAH). Type Subsidiary StatusSee details»
Nemzeti Cégtár - nemzeticegtar.hu
Actelion Pharmaceuticals Hungaria Kft. Teljes név. Actelion Pharmaceuticals Hungaria Korlátolt FelelÅ‘sségű Társaság. Alapítás éve. 2011. Adószám. 23347768-2-42. Ehhez a céghez az alábbi céginformációs szolgáltatásokat tudja megvásárolni Privát cégelemzés. 2 200 Ft.See details»
Actelion Ltd Profile: Summary - OpenSecrets
Actelion Ltd organization profile. Contributions in the 2016 cycle: $25,009. Lobbying in 2016: $0. Lobbying in 2015: $50,000. Outside Spending in the 2016 cycle: $0.See details»
Actelion Pharmaceuticals Ltd. - Swiss Biotech
Headquartered in Allschwil, Actelion is part of the Johnson & Johnson Family of Companies. Its ground-breaking research and medicines have been a key contributor to improve the lives of people affected by pulmonary hypertension, …See details»
Actelion | Company Overview & News - Forbes
Actelion Ltd is a Switzerland-based biopharmaceutical Company that focuses on the discovery, development and commercialization of treatments. Its products specialize in conditions related to the ...See details»
6 questions investors may have about - Johnson & Johnson
May 16, 2017 Johnson & Johnson recently announced it was making a significant business move: the acquisition of Actelion, a biopharmaceutical company based in Switzerland. The all-cash, $30 billion deal—which is immediately preceded by the demerger of Actelion’s R&D organization and early-stage compounds into a standalone company—will expand Johnson & …See details»
Actelion Pharmaceuticals Hungaria Kft. - Céginformáció
Actelion Pharmaceuticals Hungaria Korlátolt FelelÅ‘sségű Társaság - short credit report on date 17/10/2024 Actelion Pharmaceuticals Hungaria Kft. short credit report, official company document downloadSee details»
ACTELION: CREATING VALUE TOGETHER - Nomura Holdings
Note: Actelion was first listed at the Swiss Stock Exchange (SIX) New Market on 6 April 2000 at a price of CHF 260 per share (equivalent to a price of CHF 13 after two stock splits which occurred in 2001 and 2007). ... Adapt our organization to support further growth ...See details»
Pulmonary Hypertension Overview - Janssen
At Janssen, we are spearheading a new era for pulmonary hypertension (PH), working to transform the disease into a long-term manageable condition, so that patients can live a normal life. Building on Actelion's 20-year heritage of pioneering innovation, we are working to ensure that we reach more patients and support them to receive optimal treatment. We continue to …See details»
Actelion | Digital Health Corporate Profiles | HealthTech Alpha
Actelion is a Pharmaceutical focused corporation. Discover Digital Health profiles, team, funding and valuation with HealthTech Alpha. ... Its portfolio of PAH treatments covers the spectrum of disease, from World Health Organization (WHO) Functional Class (FC) II through to Functional Class (FC) IV, with oral, inhaled and intravenous ...See details»
Actelion | European Clinical Trials Information Network
Actelion is a Swiss biopharmaceutical company that was founded in 1997 by five scientists. The company's focus is on dev. Menu. Search for Clinical Trials. Autoimmunity. Cancers. Cardiovascular and Blood Diseases. CNS Disorders. Endocrine Diseases. Genetic Diseases. Liver Diseases. Metabolic Diseases.See details»
List of Pharmaceutical Companies In Budapest In 2025 - AeroLeads
Actelion.hu. Location: Budapest, Founded: 2003-12-01 Employees: 101-250 Get Verified Emails for 101-250 Janssen-Cilag Employees ... Top Civic & Social Organization Companies In Budapest Top Health, Wellness And Fitness Companies In Budapest Top Sports Companies In Budapest ...See details»
Actelion - Wikiwand
History. Actelion was founded in 1997 [11] by husband and wife team Jean-Paul and Martine Clozel [12] together with three colleagues after F. Hoffmann-La Roche cut their funding for Martine's cardiovascular program. They founded Actelion to work on a drugs for rare diseases and retained the rights to the intellectual property from Roche, including the molecule leading …See details»